ARPC5 |
ARPC5, ARC16: Actin-related protein 2/3 complex subunit 5 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
4.362 |
Evidence |
|
CAP1 |
CAP1, CAP: Adenylyl cyclase-associated protein 1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
4.362 |
Evidence |
|
ARPC3 |
ARPC3, ARC21: Actin-related protein 2/3 complex subunit 3 |
MSN |
MSN: Moesin |
4.362 |
Evidence |
|
ARPC5 |
ARPC5, ARC16: Actin-related protein 2/3 complex subunit 5 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
4.362 |
Evidence |
|
ARRB2 |
IPI00027355 |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
4.355 |
Evidence |
|
ASGR1 |
ASGR1: Asialoglycoprotein receptor 1 |
ANGPTL3 |
ANGPTL3, ANGPT5, UNQ153/PRO179: Angiopoietin-related protein 3 precursor |
4.355 |
Evidence |
|
RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
4.355 |
Evidence |
O
|
RNASE4 |
ANG, RNASE5: Angiogenin precursor |
PROC |
PROC: Vitamin K-dependent protein C precursor |
4.355 |
Evidence |
|
F10 |
F10: Coagulation factor X precursor |
PON1 |
IPI00555746 |
4.355 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
C8G |
C8G: Complement component C8 gamma chain precursor |
4.355 |
Evidence |
|
HRG |
HRG: Histidine-rich glycoprotein precursor |
C8A |
C8A: Complement component C8 alpha chain precursor |
4.355 |
Evidence |
|
AHSG |
AHSG, FETUA, PRO2743: Alpha-2-HS-glycoprotein precursor |
PROC |
PROC: Vitamin K-dependent protein C precursor |
4.355 |
Evidence |
|
F10 |
F10: Coagulation factor X precursor |
APOC3 |
APOC3: Apolipoprotein C-III precursor |
4.355 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
4.355 |
Evidence |
|
RNASE4 |
ANG, RNASE5: Angiogenin precursor |
C8A |
C8A: Complement component C8 alpha chain precursor |
4.355 |
Evidence |
|
APOC4 |
APOC2, APC2: Apolipoprotein C-II precursor |
PROC |
PROC: Vitamin K-dependent protein C precursor |
4.355 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
ORM2 |
ORM2, AGP2: Alpha-1-acid glycoprotein 2 precursor |
4.355 |
Evidence |
|
C8G |
C8G: Complement component C8 gamma chain precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
4.355 |
Evidence |
|
AHSG |
AHSG, FETUA, PRO2743: Alpha-2-HS-glycoprotein precursor |
C8A |
C8A: Complement component C8 alpha chain precursor |
4.355 |
Evidence |
|
F10 |
F10: Coagulation factor X precursor |
AHSG |
AHSG, FETUA, PRO2743: Alpha-2-HS-glycoprotein precursor |
4.355 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
APOC3 |
APOC3: Apolipoprotein C-III precursor |
4.355 |
Evidence |
|
RNASE4 |
ANG, RNASE5: Angiogenin precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
4.355 |
Evidence |
|
APOC3 |
APOC3: Apolipoprotein C-III precursor |
PROC |
PROC: Vitamin K-dependent protein C precursor |
4.355 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
HAMP |
HAMP, HEPC, UNQ487/PRO1003, LEAP1: Hepcidin precursor |
4.355 |
Evidence |
|
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
ORM2 |
ORM2, AGP2: Alpha-1-acid glycoprotein 2 precursor |
4.355 |
Evidence |
|